Addressing Quality Control Challenges in Drug Manufacturing

By: Hridkamal Roy, Assistant Editor, India Pharma Outlook

New manufacturing standards have been imposed on pharmaceutical companies by the government in order to address the safety and quality related concerns associated with drugs...

Unleashing the Power of Bioprinting in Biotechnology

By: Bramhanapalli Nalini, Content Writer

Bioprinting is a cutting-edge biotechnology innovation that is significant due to its potential to revolutionize healthcare, research and personalized medicine.

Behind the Label: Understanding Organic Certification in Herbal Products

By: Hima P M, Assistant Editor

Herbal fraudulent including claiming about false herbal ingredients and misleading claims on curing of various diseases are not new. The herbal fraudsters range from local sellers on street to some brands which have almost spread their wings.

The Impact of Potential Gen AI Integration on Pharma Companies

By: Rejith P R, Correspondent, India Pharma Outlook

Approximately 48% of organizations in the healthcare and pharma sectors plan to integrate their first generative artificial intelligence solution within one year. While 28% of the firms have already implemented AI technology in their business...

Tapping the Power of Real-World Evidence in Drug Development

By: Darshan.K, Correspondent, India Pharma Outlook Team

Real-world evidence (RWE) allows for the inclusion of a wide spectrum of patients, indicative of real-world clinical settings. This diversity has enhanced the understanding of how drugs perform across various demographics and clinical subgroups, p...

Beating Generics Competition in the Pharma Sector

By: Hridkamal Roy, Assistant Editor, India Pharma Outlook

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has achieved yet another landmark in the history of generic drugs and sold medicines worth 1000 Crore INR last year...

© 2024 India Pharma Outlook. All Rights Reserved.